Michael Alifrangis

机构：University of Copenhagen, Copenhagen University Hospital, Rigshospitalet · ORCID：0000-0002-3835-3333

发表论文 216 篇 · 总被引 6543 次 · h-index 46

代表论文

• Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial (2023 · The Lancet · 被引 74)
• Identification of the PfK13 mutations R561H and P441L in the Democratic Republic of Congo (2023 · International Journal of Infectious Diseases · 被引 49)
• Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug (2024 · The Lancet Infectious Diseases · 被引 37)
• A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria (2023 · Malaria Journal · 被引 37)
• Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon (2023 · International Journal of Infectious Diseases · 被引 24)
• Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology (2024 · PLoS Medicine · 被引 16)